FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to medicine and pharmaceutical industry, and concerns a method for preparing a dosage form of a hypolipidemic, hypoglycemic agent of thioctic (α-lipoic) acid. A mixture of thioctic acid, microcrystalline cellulose and lactose is wetted with hydroxypropyl methyl cellulose in the mixture of water and ethanol; the wetted mass is mixed, dried, granulated; the granulate is added with magnesium alumomethasilicate, primojel, magnesium and/or calcium stearate, sodium stearylfumarate, aerosil and/or talc; the tablets are pressed and coated with the film Opadry II. As a result, there are produced the coated tablets containing thioctic acid 300 mg and 600 mg as the active substance.
EFFECT: prepared drug preparation provides effective daily dosage - 600 mg/day for 1 - 2 intakes; the preparation is storage stable.
2 cl, 4 ex
Title | Year | Author | Number |
---|---|---|---|
AGENT BASED ON DRY MOTHERWORT EXTRACT AND METHOD FOR PRODUCTION THEREOF | 2015 |
|
RU2589507C1 |
DRUG BASED ON TETRAMETILTETRAAZOBITSIKLOOKTANDION AND METHOD FOR ITS PRODUCTION | 2012 |
|
RU2611194C2 |
SOLID DOSAGE FORM OF AZITHROMYCIN | 2012 |
|
RU2498805C1 |
METHOD OF OBTAINING MEDICAL FORM OF TRIMETAZIDINE OF PROLONGED ACTION | 2012 |
|
RU2530558C2 |
PERORAL MEDICINAL FORM WITH IMMEDIATE RELEASE OF POORLY-SOLUBLE ACTIVE SUBSTANCE | 2005 |
|
RU2382649C2 |
PHARMACEUTICAL COMPOSITIONS CONTAINING DORAVIRINE, TENOFOVIR DISOPROXIL FUMARATE AND LAMIVUDINE | 2016 |
|
RU2736941C2 |
METHOD FOR PREPARING SOLID, ORAL PHARMACEUTICAL FORMULATION | 2009 |
|
RU2493850C2 |
SOLID INDIVIDUAL HIGH 2-ETHYL-6-METHYL-3-PYRIDIN-3-OLE HYDROCHLORIDE DOSAGE FORM AND METHOD FOR PREPARING IT | 2010 |
|
RU2448686C1 |
METHOD FOR MAKING SOLID ORAL PHARMACEUTICAL COMPOSITION | 2004 |
|
RU2379036C2 |
PHARMACEUTICAL COMPOSITION CONTAINING DESLORATADINE (VERSIONS) | 2013 |
|
RU2537169C1 |
Authors
Dates
2012-04-27—Published
2011-04-13—Filed